| scholarly article | Q13442814 |
| P50 | author | Dionéia Araldi | Q42318097 |
| Eugen V. Khomula | Q44684329 | ||
| Jon D Levine | Q86533498 | ||
| P2093 | author name string | Luiz F Ferrari | |
| P2860 | cites work | Opioid Abuse in Chronic Pain--Misconceptions and Mitigation Strategies | Q26749305 |
| Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics | Q26782928 | ||
| Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations | Q28284921 | ||
| Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine | Q28371472 | ||
| Intraoperative high dose fentanyl induces postoperative fentanyl tolerance | Q28372949 | ||
| Additive anti-hyperalgesia of electroacupuncture and intrathecal antisense oligodeoxynucleotide to interleukin-1 receptor type I on carrageenan-induced inflammatory pain in rats | Q28582702 | ||
| Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence | Q28590279 | ||
| Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification | Q30248205 | ||
| A Systematic Review and Meta-Analysis of the Global Burden of Chronic Pain Without Clear Etiology in Low- and Middle-Income Countries: Trends in Heterogeneous Data and a Proposal for New Assessment Methods | Q31122310 | ||
| Shared mechanisms for opioid tolerance and a transition to chronic pain | Q33803874 | ||
| Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. | Q33989450 | ||
| Role of TRPM8 in dorsal root ganglion in nerve injury-induced chronic pain | Q34082104 | ||
| The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey | Q34134400 | ||
| A comprehensive review of opioid-induced hyperalgesia. | Q34171213 | ||
| Light scattering and birefringence changes during nerve activity | Q34237107 | ||
| Dissociation of bradykinin-induced prostaglandin formation from phosphatidylinositol turnover in Swiss 3T3 fibroblasts: evidence for G protein regulation of phospholipase A2. | Q34344960 | ||
| Opioid induced hyperalgesia in anesthetic settings | Q34613490 | ||
| Exploring the opioid system by gene knockout | Q34641459 | ||
| Plasma membrane mechanisms in a preclinical rat model of chronic pain | Q34762388 | ||
| Ryanodine receptor calcium release channels | Q34882627 | ||
| Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli | Q34981716 | ||
| Dissociation of the opioid receptor mechanisms that control mechanical and heat pain | Q34986633 | ||
| Endoplasmic reticulum Ca(2+) handling in excitable cells in health and disease | Q35122788 | ||
| Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. | Q35213193 | ||
| Generation of a pain memory in the primary afferent nociceptor triggered by PKCε activation of CPEB. | Q35833776 | ||
| Carrageenan induced phosphorylation of Akt is dependent on neurokinin-1 expressing neurons in the superficial dorsal horn | Q35834031 | ||
| Ca2+ Diffusion through Endoplasmic Reticulum Supports Elevated Intraterminal Ca2+ Levels Needed to Sustain Synaptic Release from Rods in Darkness. | Q35941425 | ||
| Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain | Q36038255 | ||
| Pain from intra-articular NGF or joint injury in the rat requires contributions from peptidergic joint afferents | Q36055163 | ||
| Age-dependent opioid escalation in chronic pain patients | Q36141383 | ||
| Signaling Over Distances | Q36539447 | ||
| Molecular mechanisms of opioid receptor-dependent signaling and behavior | Q36974487 | ||
| Peripheral administration of translation inhibitors reverses increased hyperalgesia in a model of chronic pain in the rat. | Q36979846 | ||
| Marked Sexual Dimorphism in the Role of the Ryanodine Receptor in a Model of Pain Chronification in the Rat. | Q37157308 | ||
| Adenosine-A1 receptor agonist induced hyperalgesic priming type II. | Q37308329 | ||
| Critical role of nociceptor plasticity in chronic pain | Q37603560 | ||
| μ-Opioid inhibition of Ca2+ currents and secretion in isolated terminals of the neurohypophysis occurs via ryanodine-sensitive Ca2+ stores | Q37617407 | ||
| Loss of μ opioid receptor signaling in nociceptors, but not microglia, abrogates morphine tolerance without disrupting analgesia | Q37629809 | ||
| Second messengers mediating the expression of neuroplasticity in a model of chronic pain in the rat. | Q37704685 | ||
| Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors | Q38348174 | ||
| Opioid-induced hyperalgesia in chronic pain patients and the mitigating effects of gabapentin | Q38527782 | ||
| Ablating spinal NK1-bearing neurons eliminates the development of pain and reduces spinal neuronal hyperexcitability and inflammation from mechanical joint injury in the rat. | Q38585348 | ||
| What Do We Know About the Pathophysiology of Chronic Pain? Implications for Treatment Considerations | Q38651179 | ||
| Opioid-induced hyperalgesia: Cellular and molecular mechanisms | Q38805809 | ||
| From contraction to gene expression: nanojunctions of the sarco/endoplasmic reticulum deliver site- and function-specific calcium signals | Q38885377 | ||
| Assessment of Psychosocial and Functional Impact of Chronic Pain. | Q38944380 | ||
| Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron. | Q38993652 | ||
| Does Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?: A Double-blind, Randomized, Crossover Trial. | Q40224328 | ||
| Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line SPE-LC-MS/MS. | Q40274589 | ||
| Measuring nerve excitation with polarized light. | Q40796079 | ||
| Ryanodine: a modifier of sarcoplasmic reticulum calcium release in striated muscle | Q41244080 | ||
| Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat. | Q41295061 | ||
| Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming | Q41300169 | ||
| Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. | Q41348392 | ||
| Role of protein kinase A in the maintenance of inflammatory pain | Q41611112 | ||
| Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. | Q41740218 | ||
| Involvement of the mu-opiate receptor in peripheral analgesia | Q42189120 | ||
| Sexual Dimorphism in a Reciprocal Interaction of Ryanodine and IP3 Receptors in the Induction of Hyperalgesic Priming | Q42318088 | ||
| Dissociation of tolerance and dependence for opioid peripheral antinociception in rats | Q42549822 | ||
| Ryanodine-receptor-driven intracellular calcium dynamics underlying spatial association of synaptic plasticity | Q42625002 | ||
| Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing | Q42775852 | ||
| Restriction of transient receptor potential vanilloid-1 to the peptidergic subset of primary afferent neurons follows its developmental downregulation in nonpeptidergic neurons | Q42848498 | ||
| Opioid tolerance: the clinical perspective | Q43070666 | ||
| The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance | Q43969879 | ||
| Spinal neurons that possess the substance P receptor are required for the development of central sensitization. | Q44186001 | ||
| Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal | Q44341537 | ||
| Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice | Q44343189 | ||
| Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms | Q44344074 | ||
| Selective attenuation of mu-opioid receptor-mediated effects in rat sensory neurons by intrathecal administration of antisense oligodeoxynucleotides. | Q44344295 | ||
| Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase | Q44352021 | ||
| Intrathecal substance p-saporin attenuates operant escape from nociceptive thermal stimuli | Q44451101 | ||
| CX3CL1/CX3CR1 regulates nerve injury-induced pain hypersensitivity through the ERK5 signaling pathway | Q44882840 | ||
| Effects of isolectin B4-conjugated saporin, a targeting cytotoxin, on bladder overactivity induced by bladder irritation | Q44963309 | ||
| Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats | Q45245132 | ||
| Hypotonicity induces TRPV4-mediated nociception in rat. | Q45945316 | ||
| CD44 Signaling Mediates High Molecular Weight Hyaluronan-induced Anti-hyperalgesia. | Q46134808 | ||
| Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system | Q46150150 | ||
| Marked sexual dimorphism in 5-HT1 receptors mediating pronociceptive effects of sumatriptan | Q46160367 | ||
| Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy | Q46175650 | ||
| Co-expression of nociceptor properties in dorsal root ganglion neurons from the adult rat in vitro | Q46801686 | ||
| Inhibitory ryanodine prevents ryanodine receptor-mediated Ca²⁺ release without affecting endoplasmic reticulum Ca²⁺ content in primary hippocampal neurons. | Q48359048 | ||
| Intrathecal PLC(β3) oligodeoxynucleotides antisense potentiates acute morphine efficacy and attenuates chronic morphine tolerance | Q48448807 | ||
| The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats | Q48473150 | ||
| Role of GPCR (mu-opioid)-receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II). | Q49981100 | ||
| A method to perform direct transcutaneous intrathecal injection in rats. | Q50767149 | ||
| Anti-nociceptive effects of selectively destroying substance P receptor-expressing dorsal horn neurons using [Sar9,Met(O2)11]-substance P-saporin: behavioral and anatomical analyses. | Q51757538 | ||
| Direct cutaneous hyperalgesia induced by adenosine | Q56611045 | ||
| The Cell and Molecular Basis of Mechanical, Cold, and Inflammatory Pain | Q57771834 | ||
| Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones | Q70114271 | ||
| Measurement of intracellular free calcium in monkey kidney cells with aequorin | Q71607808 | ||
| The painful reality | Q73085105 | ||
| Cytotoxic targeting of isolectin IB4-binding sensory neurons | Q77335131 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fentanyl | Q407541 |
| P304 | page(s) | 2226-2245 | |
| P577 | publication date | 2018-02-05 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals | |
| P478 | volume | 38 |
| Q90210561 | Does epigenetic 'memory' of early-life stress predispose to chronic pain in later life? A potential role for the stress regulator FKBP5 |
| Q88933804 | Endogenous and Exogenous Opioids in Pain |
| Q91839665 | In Vitro Nociceptor Neuroplasticity Associated with In Vivo Opioid-Induced Hyperalgesia |
| Q57813827 | Mu-Opioid Receptor (MOR) Biased Agonists Induce Biphasic Dose-dependent Hyperalgesia and Analgesia, and Hyperalgesic Priming in the Rat |
| Q93085569 | Perioperative opioid analgesia-when is enough too much? A review of opioid-induced tolerance and hyperalgesia |
| Q92825246 | Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming |
| Q89555422 | The prolactin receptor long isoform regulates nociceptor sensitization and opioid-induced hyperalgesia selectively in females |
Search more.